Home » Analysis & Comment » Page 39
This is a fine time to be British. Indeed, to be proud to be British. You would not, to be sure, think so from this past week in London – as the House of Commons humiliated Prime Minister Theresa May by throwing out her plan […]
Readers discuss President Trump’s rising approval numbers, how Joe Biden is “sidelined” and whether Gov. Andrew Cuomo should be drafted as the Democratic nominee. To the Editor: Re “Trump Is Hurting His Own Re-election Chances” (column, March 30): Shortly after David Leonhardt’s insightful column first […]
It’s not too late to start protecting jobs or to make medical care for Covid-19 free. By Emmanuel Saez and Gabriel Zucman The authors are economists at the University of California, Berkeley. The coronavirus pandemic is laying bare structural deficiencies in America’s social programs. The […]
LONDON • Trying to identify the long-term consequences of a crisis well before it is over is always a risky business, not only because circumstances can change, but also because the perspective one has during a crisis is shaped by episodes that look important now, […]
FRANKFURT/VIENNA (Reuters) – AMS (AMS.S) shares fell below the price at which the Austrian sensor maker is raising new equity on Monday, in the latest hurdle to its planned purchase of German lighting group Osram. Austria’s AMS began offering new shares at 9.20 Swiss francs […]
(Reuters) – Australia’s Healius Ltd (HLS.AX) on Monday turned down a A$2.12 billion ($1.31 billion) takeover offer from private equity firm Partners Group (PGHN.S), saying it undervalued the medical center operator. Healius, however, said it was open to further talks with Partners Group to get […]
(Reuters) – Even as the market rout fueled by the coronavirus brings most corporate dealmaking to a halt, buyout firms are competing fiercely to acquire Air Liquide SA’s (AIRP.PA) disinfectant making unit Schuelke, as demand for hand sanitizers and medical cleaning supplies surges due to […]